Merck Sharp & Dohme Launches Januvia In China To Join Race In Second-Largest Diabetes Market
This article was originally published in The Pink Sheet Daily
Executive Summary
China has more than 1 million individuals newly diagnosed with diabetes each year.
You may also be interested in...
Lilly Launches Byetta In China To Target World's Second Largest Diabetes Market
SHANGHAI - Eli Lilly announced Aug. 23 that the company has launched its GLP-1 agonist Byetta (exenatide) in China, and the drug will be in hospitals in first-tier cities by the end of September
Sanofi-Aventis Sees Diversifying In China As Key To Success; Expands Capacity For Diabetes Treatment Lantus
SHANGHAI - Sanofi-Aventis announced a series of expansion plans in China aimed at diversifying its portfolio, the CEO said April 21 during his first trip to China
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.